Information in this section pertains to all global PEN® partners except where country flags are
visible. Click on the flag(s) for country-specific information. If a country flag is not listed, there is
no information specific to that country.
[A] The following conclusions are supported by good evidence:
Evidence from clinical trials demonstrates that folic acid and vitamin B12 supplementation reduce plasma homocysteine levels; however, B vitamin supplementation has not been shown to be beneficial in reducing the risk of cardiovascular events in older adults with pre-existing cardiovascular disease. Folic acid and B-vitamin supplements are therefore not recommended to prevent cardiovascular disease in high risk